New pill targets hidden heart risk in High-Risk patients
NCT ID NCT06816264
Summary
This study tested whether a new oral medication called HRS-5346 could safely lower levels of lipoprotein(a), a fatty particle in the blood linked to heart attack and stroke risk. It involved 120 adults who already had heart disease or were at high risk for it and had high lipoprotein(a) levels. Participants were randomly assigned to receive either the real pill or a placebo to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT OF LIPOPROTEIN DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100000, China
Conditions
Explore the condition pages connected to this study.